ImmunoACT
Karan Gera is a skilled professional in the biotechnology and life sciences sector with extensive experience in business development, project management, and research. Currently serving as the Business Development, Alliances, & Commercial Access Manager at ImmunoACT since April 2023, Karan leads international collaborations for B2B business development, focusing on gene-modified cell therapies and establishing indigenous CAR-T therapy in India. Previous roles include Global Business Development at Enzene Biosciences Ltd, where Karan managed out-licensing and technology transfer, and Marketing & Sales Executive at Therapiva India Pvt. Ltd, involving sales operations for APIs in global markets. Karan's foundational experience includes business strategy at Epione Labs and comprehensive research work during master's studies at Iowa State University, specializing in molecular and developmental biology. Educational credentials include a Master's degree from Iowa State University and a Bachelor's degree in Biotechnology from Manipal Institute of Technology.
This person is not in any teams
ImmunoACT
Spun-out from IIT-Bombay in 2018, ImmunoACT is India's pioneer in the development of the country's first indigenous Cell & Gene Therapy. With a rapidly expanding pipeline beginning with blood cancers, our mission is to provide affordable access to novel autologous CAR-T cell therapies.